{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:53Z","timestamp":1761519173342},"reference-count":46,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2017,2,1]]},"DOI":"10.1080\/03007995.2016.1251893","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T07:28:52Z","timestamp":1477034932000},"page":"231-238","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine"],"prefix":"10.1080","volume":"33","author":[{"given":"James","family":"Weatherall","sequence":"first","affiliation":[{"name":"Novo Nordisk Inc., Plainsboro, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Bloudek","sequence":"additional","affiliation":[{"name":"Xcenda LLC, Palm Harbor, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Buchs","sequence":"additional","affiliation":[{"name":"Novo Nordisk Inc., Plainsboro, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,11,18]]},"reference":[{"key":"CIT0001","unstructured":"National Diabetes Statistics Report, 2014. Centers for Disease Control and Prevention (CDC). Available at: http:\/\/www.cdc.gov\/diabetes\/data\/tatistics\/2014StatisticsReport.html. Updated 2014 [Last accessed 14 October 2015]"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2625"},{"issue":"1","key":"CIT0003","first-page":"S1","volume":"38","author":"American Diabetes Association.","year":"2015","journal-title":"Diabetes Care"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68341-4"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2258"},{"key":"CIT0007","volume-title":"Tresiba [package insert]","year":"2015"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60204-9"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60205-0"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1668"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3249"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1205"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12115"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12298"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12102"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2329"},{"key":"CIT0017","unstructured":"Statistics about diabetes: data from the National Diabetes Statistics Report, 2014. American Diabetes Association. Available at: http:\/\/www.diabetes.org\/diabetes-basics\/statistics\/[Last accessed 21 August 2015]"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2011.11.005"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18553\/jmcp.2012.18.1.21","volume":"18","author":"Yeaw J","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-014-0076-9"},{"key":"CIT0021","volume-title":"Data on file, DOF-MA-IDeg-005: Daily insulin doses used in degludec health economic model","year":"2014"},{"key":"CIT0022","unstructured":"Levemir (insulin detemir [rDNA origin] injection): starting patients on Levemir. Novo Nordisk. Available at: http:\/\/www.levemirpro.com\/prescribing\/dosing.aspx [Last accessed 17 September 2015]"},{"key":"CIT0023","unstructured":"Lantus (insulin glargine injection): structure titration to target fasting glucose. Sanofi. Available at: http:\/\/www.lantus.com\/hcp\/dosing-titration\/titration-guide.aspx [Last accessed 17 September 2015]"},{"key":"CIT0024","unstructured":"Insulin degludec and insulin degludec\/insulin aspart. NDAs 203314 and 203313. Novo Nordisk Briefing Document. Endocrinologic and Metabolic Drug Advisory Committee, 8 November 2012. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/EndocrinologicandMetabolicDrugsAdvisoryCommittee\/UCM327017.pdf [Last accessed 18 November 2015]"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.02.001"},{"key":"CIT0026","volume-title":"Data on file, DOF-MA-IDeg-003: Unit cost of severe\/non-severe hypoglycemic event","year":"2014"},{"key":"CIT0027","unstructured":"Medi-Span Price Rx. Available at: https:\/\/pricerx.medispan.com\/[Last accessed 21 September 2015]"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9017"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.882843"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12032"},{"key":"CIT0031","volume-title":"Data on file, DOF-MA-IDeg-006: Calculation of baseline annual hypoglycemia rates for use in health economic modelling","year":"2014"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0599-y"},{"key":"CIT0033","first-page":"455","volume":"18","author":"Curkendall S","year":"2011","journal-title":"J Clin Outcome Manag"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.936930"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802715199"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61929"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.686465"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.2.330"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12250"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.975234"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.971160"},{"key":"CIT0042","unstructured":"Evaluating the value of new drugs and devices. Institute for Clinical and Economic Review. September 2015. Available at: http:\/\/www.icer-review.org\/wp-content\/uploads\/2014\/01\/Slides-on-value-framework-for-national-webinar1.pdf [Last accessed 18 November 2015]"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12303"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12411"},{"key":"CIT0045","unstructured":"Suzuki JYT, Nagakura J, Shigematsu E, Terauchi Y. Usefulness of insulin degludec in Japanese type 1 diabetes. Poster presented at 74th Scientific Sessions of the American Diabetes Association. San Francisco, CA, 13\u201317 June 2014"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1058252"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2016.1251893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T15:45:34Z","timestamp":1598715934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2016.1251893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,18]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2,1]]}},"alternative-id":["10.1080\/03007995.2016.1251893"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2016.1251893","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}